Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $95.04 USD
Change Today +0.79 / 0.84%
Volume 326.1K
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John L. Higgins

Chief Executive Officer and Executive Director,Ligand Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 34 board members in 3 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. John L. Higgins has been the Chief Executive Officer of Ligand Pharmaceuticals Incorporated since January 16, 2007. Mr. Higgins serves as the President and Chief Executive Officer of Moonstone Acquisition, Inc. He served as the President of Ligand Pharmaceuticals Incorporated since January 16, 2007 until February 2, 2015. He has over 14 years of corporate development, financing, strategic planning, commercialization and investment banking experience in the Biopharmaceutical ...

Read Full Background

Corporate Headquarters*

11119 North Torrey Pines Road
La Jolla, California 92037

United States

Phone: 858-550-7500
Fax: --

Board Members Memberships*

Chief Executive Officer and Executive Director
Director, Chairman of Audit Committee, Member of Nominations & Governance Committee and Member of Executive Compensation Committee


Colgate University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$510,198

Stock Options*

Restricted Stock Awards$595,360
All Other Compensation$5,650
Exercised Options25,875
Exercised Options Value$1,497,780
Exercisable Options448,179
Exercisable Options Value$16,194,460
Unexercisable Options168,871
Unexercisable Options Value$3,752,699
Total Value of Options$21,444,938
Total Number of Options652,925

Total Compensation*

Total Annual Cash Compensation$898,945
Total Short Term Compensation$510,198
Other Long Term Compensation$601,010
Total Calculated Compensation$6,047,256
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $95.04 USD +0.79


Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at